Results 141 to 150 of about 455 (155)
Some of the next articles are maybe not open access.
The reversible biotransformation of N-acetylprocainamide in the rhesus monkey.
Arzneimittel-Forschung, 1978The specific activity of 14C-N-acetylprocainamide (14C-NAPA) was measured in the 24-h urine of two rhesus monkeys given the labelled drug i.v. Specific activity was found to decrease by 15.8% from the original value. This was attributed to an in vivo biotransformation of NAPA to procainamide (PCA) and reacetylation of PCA back to NAPA before it was ...
T L, Ding, E T, Lin, L Z, Benet
openaire +1 more source
Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
Drug metabolism and disposition: the biological fate of chemicals, 1985The influence of dietary protein deficiency on the disposition of procainamide (PA) and its major metabolite, N-acetylprocainamide (NAPA) was investigated in male Sprague-Dawley rats fed for 4 weeks on a 23 (control) or a 5% (low) protein diet ad libitum.
D, Jung, M, Nanavaty, P, Prasad
openaire +1 more source
Class I antiarrhythmic agents: Quinidine, procainamide and N-acetylprocainamide, disopyramide
Pharmacology & Therapeutics, 1983D M, Roden, R L, Woosley
openaire +2 more sources
Role of K+ channels in N-acetylprocainamide-induced relaxation of bovine tracheal smooth muscle
European Journal of Pharmacology, 2001Tsutomu Nakahara, Yoshio Tanaka
exaly
Clinical Pharmacokinetics of N-acetylprocainamide
Clinical Pharmacokinetics, 2012Stuart J Connolly
exaly
Antibodies to Nuclear Antigens in Patients Treated with Procainamide or Acetylprocainamide
New England Journal of Medicine, 1979exaly